Year archive

MESOBLAST LTD — 2025 filings

All 202 regulatory filings released by MESOBLAST LTD (MESO) in 2025, sourced directly from the official regulator.

202 Filings

2025 Period

2025 filings (202)

Filing	Released	Lang
REGISTRATION STATEMENT Capital/Financing Update	2025-12-31	English
REGISTRATION STATEMENT Capital/Financing Update	2025-12-30	English
6-K Regulatory Filings	2025-12-30	English
Mesoblast Enters into Non-Dilutive Lower Cost 5-Year Credit 2 pages 222.7KB Capital/Financing Update	2025-12-29	English
Proposed issue of securities - MSB 5 pages 19.0KB Capital/Financing Update	2025-12-29	English
Release of Shares from Voluntary Escrow 1 page 164. Share Issue/Capital Change	2025-12-29	English
6-K Regulatory Filings	2025-12-24	English
Appendix 3Y for Gregory George 3 pages 286.5KB Director's Dealing	2025-12-22	English
Ceasing to be a substantial holder 31 pages 1.3MB Major Shareholding Notification	2025-12-18	English
6-K Capital/Financing Update	2025-12-18	English
Becoming a substantial holder 45 pages 3.9MB Major Shareholding Notification	2025-12-16	English
Notification regarding unquoted securities - MSB 6 pages 20.5KB Share Issue/Capital Change	2025-12-16	English
Warrant Prospectus Related to Convertible Note Agreements 50 pages 1.1MB Capital/Financing Update	2025-12-15	English
6-K Regulatory Filings	2025-12-12	English
Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD 2 pages 219.4KB Investor Presentation	2025-12-11	English
Ceasing to be a substantial holder 4 pages 314.1KB Major Shareholding Notification	2025-12-09	English
Becoming a substantial holder 31 pages 3.3MB Major Shareholding Notification	2025-12-08	English
6-K Regulatory Filings	2025-12-04	English
Mesoblast Participation at Piper Sandler Conference 2 pages 196.7KB Regulatory Filings	2025-12-03	English
Ceasing to be a substantial holder 15 pages 449.8KB Major Shareholding Notification	2025-11-26	English
6-K Declaration of Voting Results & Voting Rights Announcements	2025-11-26	English
6-K AGM Information	2025-11-25	English
6-K Regulatory Filings	2025-11-24	English
Mesoblast Chair Message to 2025 AGM 3 pages 198.0KB AGM Information	2025-11-24	English
CEO Presentation to 2025 Annual General Meeting 23 pages 1.7MB Investor Presentation	2025-11-24	English
Ryoncil Revenue Growth Highlighted in AGM Trading Update 2 pages 196.2KB AGM Information	2025-11-24	English
Results of Meeting 4 pages 207.3KB Declaration of Voting Results & Voting Rights Announcements	2025-11-24	English
Mesoblast & BMT CTN to Initiate Adult aGvHD Trial of RYONCIL 4 pages 237.6KB Regulatory Filings	2025-11-20	English
6-K Regulatory Filings	2025-11-17	English
Appointment of Chief Financial Officer 2 pages 198.3KB Board/Management Information	2025-11-16	English
6-K Regulatory Filings	2025-11-05	English
FDA meeting on Rexlemestrocel-L, CLBP and Opioid Cessation 3 pages 224.5KB Regulatory Filings	2025-11-04	English
6-K Director's Dealing	2025-10-29	English
Becoming a substantial holder 25 pages 2.7MB Major Shareholding Notification	2025-10-28	English
6-K Regulatory Filings	2025-10-28	English
Notification regarding unquoted securities - MSB 6 pages 18.4KB Share Issue/Capital Change	2025-10-27	English
Change of Director's Interest Notice 2 pages 232.5KB Director's Dealing	2025-10-27	English
Appendix 4G and Corporate Governance Statement 22 pages 585.7KB Regulatory Filings	2025-10-26	English
Notice of Annual General Meeting and Proxy Form 31 pages 678.9KB AGM Information	2025-10-26	English
Annual Report to Shareholders 272 pages 3.9MB Annual Report FY 2025	2025-10-26	English
Ceasing to be a substantial holder 4 pages 476.8KB Major Shareholding Notification	2025-10-22	English
6-K Regulatory Filings	2025-10-22	English
Becoming a substantial holder 27 pages 2.5MB Major Shareholding Notification	2025-10-21	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 548.6KB Interim / Quarterly Report Q1 2026	2025-10-19	English
6-K Regulatory Filings	2025-10-15	English
Ceasing to be a substantial holder 30 pages 1.2MB Major Shareholding Notification	2025-10-14	English
Becoming a substantial holder 55 pages 6.4MB Major Shareholding Notification	2025-10-13	English
Appendix 3Y for Eric Rose 3 pages 263.3KB Director's Dealing	2025-10-13	English
Application for quotation of securities - MSB 7 pages 20.9KB Share Issue/Capital Change	2025-10-13	English
Notification regarding unquoted securities - MSB 6 pages 18.5KB Share Issue/Capital Change	2025-10-13	English
Notification of cessation of securities - MSB 4 pages 15.3KB Regulatory Filings	2025-10-13	English
6-K Regulatory Filings	2025-10-07	English
Ryoncil Revenues Increase 66% in Second Quarter Post Launch 2 pages 215.8KB Earnings Release Q1 2026	2025-10-06	English
6-K Regulatory Filings	2025-10-03	English
Ryoncil Receives CMS (Medicaid) J-Code for Reimbursement 2 pages 219.3KB Regulatory Filings	2025-10-02	English
6-K Regulatory Filings	2025-09-29	English
Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs 2 pages 172.3KB Regulatory Filings	2025-09-25	English
Ceasing to be a substantial holder 7 pages 675.7KB Major Shareholding Notification	2025-09-21	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-09-17	English
Becoming a substantial holder 4 pages 154.7KB Regulatory Filings	2025-09-15	English
Becoming a substantial holder 29 pages 471.8KB Major Shareholding Notification	2025-09-15	English
6-K Regulatory Filings	2025-09-15	English
6-K Director's Dealing	2025-09-15	English
Ryoncil Launch Highlighted at Global Healthcare Conferences 2 pages 171.6KB Capital/Financing Update	2025-09-14	English
Ceasing to be a substantial holder 10 pages 408.6KB Major Shareholding Notification	2025-09-14	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-09-12	English
Change in substantial holding 5 pages 105.7KB Regulatory Filings	2025-09-11	English
Change of Director's Interest Notice 3 pages 321.1KB Director's Dealing	2025-09-11	English
6-K Capital/Financing Update	2025-09-04	English
Mesoblast Option to Issue up to US$50m Convertible Notes 3 pages 175.9KB Capital/Financing Update	2025-09-03	English
Proposed issue of securities - MSB 5 pages 19.3KB Capital/Financing Update	2025-09-03	English
6-K Investor Presentation	2025-08-29	English
20-F Annual Report FY 2025	2025-08-29	English
Preliminary Final Report including Appendix 4E 270 pages 3.4MB Annual Report FY 2025	2025-08-28	English
Annual Financial Results Presentation 35 pages 2.3MB Annual Report FY 2025	2025-08-28	English
MSB Annual Financial Results and Operational Update 9 pages 561.9KB Annual Report FY 2025	2025-08-28	English
Becoming a substantial holder 28 pages 470.3KB Major Shareholding Notification	2025-08-28	English
6-K Regulatory Filings	2025-08-27	English
Mesoblast 2025 Full Year Financial Results Webcast 2 pages 203.9KB Report Publication Announcement	2025-08-26	English
Ceasing to be a substantial holder 11 pages 1.1MB Major Shareholding Notification	2025-08-24	English
Becoming a substantial holder 25 pages 2.6MB Major Shareholding Notification	2025-07-28	English
Ceasing to be a substantial holder 26 pages 1.8MB Major Shareholding Notification	2025-07-24	English
Ceasing to be a substantial holder 12 pages 1.1MB Major Shareholding Notification	2025-07-24	English
Becoming a substantial holder 43 pages 2.3MB Major Shareholding Notification	2025-07-22	English
Ceasing to be a substantial holder 28 pages 1.8MB Major Shareholding Notification	2025-07-20	English
6-K Regulatory Filings	2025-07-18	English
Becoming a substantial holder 44 pages 2.6MB Major Shareholding Notification	2025-07-17	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 548.4KB Interim / Quarterly Report Q4 2025	2025-07-17	English
6-K Regulatory Filings	2025-07-15	English
Notification regarding unquoted securities - MSB 6 pages 18.7KB Share Issue/Capital Change	2025-07-13	English
Application for quotation of securities - MSB 7 pages 20.9KB Share Issue/Capital Change	2025-07-13	English
Notification regarding unquoted securities - MSB 5 pages 16.8KB Share Issue/Capital Change	2025-07-13	English
Notification of cessation of securities - MSB 4 pages 14.8KB Regulatory Filings	2025-07-13	English
Ceasing to be a substantial holder 28 pages 1.6MB Major Shareholding Notification	2025-07-07	English
Becoming a substantial holder 36 pages 2.3MB Major Shareholding Notification	2025-07-06	English
6-K Regulatory Filings	2025-07-01	English
Mesoblast and FDA Align on Key Items for Revascor BLA 2 pages 200.0KB Regulatory Filings	2025-06-30	English
Ceasing to be a substantial holder 28 pages 1.6MB Major Shareholding Notification	2025-06-25	English
Ceasing to be a substantial holder 3 pages 304.2KB Major Shareholding Notification	2025-06-17	English
Becoming a substantial holder 34 pages 2.1MB Major Shareholding Notification	2025-06-16	English
Ceasing to be a substantial holder 25 pages 1.7MB Major Shareholding Notification	2025-06-15	English
6-K Regulatory Filings	2025-06-12	English
Mesoblast Maintains Momentum with FDA 3 pages 205.4KB Regulatory Filings	2025-06-11	English
Becoming a substantial holder 6 pages 507.7KB Major Shareholding Notification	2025-06-05	English
Becoming a substantial holder 36 pages 2.3MB Major Shareholding Notification	2025-06-04	English
Ceasing to be a substantial holder 22 pages 1.6MB Major Shareholding Notification	2025-06-02	English
Becoming a substantial holder 36 pages 3.3MB Major Shareholding Notification	2025-06-02	English
6-K Regulatory Filings	2025-05-15	English
FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval 2 pages 191.6KB Regulatory Filings	2025-05-14	English
Becoming a substantial holder 33 pages 2.1MB Major Shareholding Notification	2025-05-13	English
Ceasing to be a substantial holder 18 pages 1.4MB Major Shareholding Notification	2025-05-08	English
Becoming a substantial holder 33 pages 2.2MB Major Shareholding Notification	2025-05-07	English
Ceasing to be a substantial holder 6 pages 226.8KB Major Shareholding Notification	2025-05-06	English
Becoming a substantial holder 41 pages 355.4KB Major Shareholding Notification	2025-05-01	English
6-K Regulatory Filings	2025-04-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 540.1KB Interim / Quarterly Report Q3 2025	2025-04-29	English
6-K Regulatory Filings	2025-04-29	English
Director Appointment 2 pages 196.2KB Board/Management Information	2025-04-28	English
Initial Director's Interest Notice 2 pages 246.2KB Director's Dealing	2025-04-28	English
6-K Director's Dealing	2025-04-24	English
Appendix 3Y for Gregory George 3 pages 283.7KB Director's Dealing	2025-04-23	English
6-K Regulatory Filings	2025-04-17	English
Mesoblast Extends Ryoncil Payer Coverage To 104M US Lives 2 pages 200.2KB Capital/Financing Update	2025-04-16	English
6-K Regulatory Filings	2025-04-15	English
Notification regarding unquoted securities - MSB 6 pages 18.7KB Share Issue/Capital Change	2025-04-13	English
Application for quotation of securities - MSB 7 pages 20.9KB Share Issue/Capital Change	2025-04-13	English
Notification regarding unquoted securities - MSB 5 pages 16.8KB Share Issue/Capital Change	2025-04-13	English
Notification of cessation of securities - MSB 4 pages 14.8KB Regulatory Filings	2025-04-13	English
6-K Regulatory Filings	2025-04-09	English
Notification regarding unquoted securities - MSB 6 pages 19.4KB Share Issue/Capital Change	2025-04-07	English
Appendix 3Y - Silviu Itescu, Eric Rose and Philip Krause 8 pages 352.7KB Director's Dealing	2025-04-07	English
6-K Regulatory Filings	2025-04-04	English
Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs 2 pages 201.1KB Regulatory Filings	2025-04-03	English
6-K Regulatory Filings	2025-04-03	English
Meeting Requested with FDA on Revascor Accelerated Approval 2 pages 200.1KB Regulatory Filings	2025-04-02	English
6-K Regulatory Filings	2025-03-31	English
First Children To Begin Treatment, Medicaid Covers Ryoncil 2 pages 202.8KB Regulatory Filings	2025-03-30	English
6-K Regulatory Filings	2025-03-27	English
Ryoncil Is Now Available For Purchase In The United States 2 pages 204.5KB Regulatory Filings	2025-03-26	English
6-K Regulatory Filings	2025-03-14	English
Ryoncil Published in All Four Major Drug Pricing Compendia 2 pages 199.1KB Regulatory Filings	2025-03-13	English
6-K Director's Dealing	2025-03-13	English
Appendix 3Y for Gregory George 3 pages 284.5KB Director's Dealing	2025-03-12	English
CEO Presentation at ISCT North America 20 pages 1.4MB Investor Presentation	2025-03-12	English
6-K Regulatory Filings	2025-03-12	English
CEO to Deliver Featured Presentation at ISCT North America 2 pages 211.5KB Regulatory Filings	2025-03-11	English
6-K Director's Dealing	2025-03-07	English
Appendix 3Y for Eric Rose 3 pages 300.5KB Director's Dealing	2025-03-06	English
Notification regarding unquoted securities - MSB 6 pages 18.3KB Share Issue/Capital Change	2025-03-06	English
Appendix 3Y for Jane Bell 2 pages 256.7KB Director's Dealing	2025-03-06	English
Appendix 3Y and replacement Appendix 3X for Gregory George 7 pages 436.5KB Director's Dealing	2025-03-06	English
Mesoblast Added to S&P ASX200 Index 2 pages 202.2KB Investor Presentation	2025-03-05	English
6-K Investor Presentation	2025-02-28	English
6-K Interim / Quarterly Report	2025-02-27	English
ZSP: Arcadium Lithium PLC to be removed from the S&P/ASX 200 2 pages 146.8KB Delisting Announcement	2025-02-27	English
Half Year Report and Accounts (including Appendix 4D) 104 pages 2.1MB Interim / Quarterly Report H1 2025	2025-02-26	English
Corporate Presentation and Half Year Financial Results 37 pages 2.3MB Interim / Quarterly Report H1 2025	2025-02-26	English
Ryoncil Pricing Set and Available This Quarter 8 pages 555.3KB Interim / Quarterly Report H1 2025	2025-02-26	English
6-K Director's Dealing	2025-02-25	English
Mesoblast 2025 Half Year Financial Results Webcast 2 pages 211.6KB Report Publication Announcement	2025-02-25	English
Director Appointment 2 pages 198.9KB Board/Management Information	2025-02-23	English
Initial Director's Interest Notice 3 pages 296.2KB Director's Dealing	2025-02-23	English
6-K Regulatory Filings	2025-02-14	English
Ryoncil Highlighted at Tandem Transplantation Meetings 3 pages 288.5KB Regulatory Filings	2025-02-13	English
Regulatory Filings 2025 Regulatory Filings	2025-02-13	English
PROSPECTUS Capital/Financing Update	2025-02-12	English
Regulatory Filings 2025 Regulatory Filings	2025-02-10	English
Regulatory Filings 2025 Regulatory Filings	2025-02-07	English
AMENDMENT NO. 1 TO FORM F-3 Capital/Financing Update	2025-02-06	English
Change in substantial holding 5 pages 219.8KB Regulatory Filings	2025-02-06	English
REGISTRATION STATEMENT Capital/Financing Update	2025-02-05	English
6-K Regulatory Filings	2025-01-31	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 521.6KB Interim / Quarterly Report Q2 2025	2025-01-30	English
Ryoncil Commercial Launch Update and Product Pipeline 5 pages 275.7KB Investor Presentation	2025-01-30	English
6-K Regulatory Filings	2025-01-24	English
Application for quotation of securities - MSB 6 pages 18.2KB Share Issue/Capital Change	2025-01-23	English
Cleansing Notice 1 page 233.8KB Capital/Financing Update	2025-01-23	English
Ceasing to be a substantial holder 22 pages 1.1MB Major Shareholding Notification	2025-01-21	English
Application for quotation of securities - MSB 6 pages 18.4KB Share Issue/Capital Change	2025-01-21	English
Cleansing Notice 1 page 214.3KB Capital/Financing Update	2025-01-21	English
Appendix 3Y for Eric Rose 3 pages 264.9KB Director's Dealing	2025-01-20	English
Cleansing Notice 1 page 214.0KB Capital/Financing Update	2025-01-19	English
Application for quotation of securities - MSB 5 pages 16.6KB Share Issue/Capital Change	2025-01-16	English
6-K Regulatory Filings	2025-01-16	English
Notification regarding unquoted securities - MSB 8 pages 26.6KB Share Issue/Capital Change	2025-01-15	English
App 3Ys S Itescu J Bell W Burns P Facchina E Rose P Krause 14 pages 522.2KB Director's Dealing	2025-01-15	English
Ceasing to be a substantial holder 7 pages 756.4KB Major Shareholding Notification	2025-01-15	English
Application for quotation of securities - MSB 7 pages 20.9KB Share Issue/Capital Change	2025-01-14	English
Notification regarding unquoted securities - MSB 5 pages 16.8KB Share Issue/Capital Change	2025-01-14	English
Notification regarding unquoted securities - MSB 6 pages 18.7KB Share Issue/Capital Change	2025-01-14	English
Notification regarding unquoted securities - MSB 6 pages 18.3KB Share Issue/Capital Change	2025-01-14	English
Notification of cessation of securities - MSB 4 pages 15.3KB Regulatory Filings	2025-01-14	English
MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH 2 pages 245.0KB Capital/Financing Update	2025-01-13	English
Proposed issue of securities - MSB 5 pages 17.2KB Capital/Financing Update	2025-01-13	English
Change in substantial holding 25 pages 1.7MB Major Shareholding Notification	2025-01-09	English
Pause in Trading 1 page 117.1KB Regulatory Filings	2025-01-09	English
Trading Halt 2 pages 230.6KB Capital/Financing Update	2025-01-09	English
Application for quotation of securities - MSB 6 pages 18.3KB Share Issue/Capital Change	2025-01-09	English
Application for quotation of securities - MSB 6 pages 18.5KB Share Issue/Capital Change	2025-01-09	English
Becoming a substantial holder 21 pages 2.2MB Major Shareholding Notification	2025-01-08	English
Ceasing to be a substantial holder 8 pages 772.3KB Major Shareholding Notification	2025-01-05	English
Proposed issue of securities - MSB 5 pages 17.7KB Capital/Financing Update	2025-01-05	English

Filings by year

2026 66 filings
2025 202 filings
2024 141 filings
2023 127 filings
2022 135 filings
2021 101 filings
2020 152 filings
2019 117 filings
2018 107 filings
2017 123 filings
2016 97 filings
2015 92 filings
2014 55 filings
2013 53 filings
2012 34 filings
2011 60 filings
2010 63 filings
2009 56 filings
2008 55 filings
2007 48 filings
2006 62 filings
2005 55 filings
2004 14 filings